This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Toyama Chemical Co., Ltd.. Active years: 2015-2018.
Company Filing History:
Years Active: 2015-2018
Title: Kimiko Morimoto: Innovator in Pharmaceutical Research
Introduction
Kimiko Morimoto is a prominent inventor based in Toyama, Japan. She has made significant contributions to the field of pharmaceutical research, particularly in the development of therapeutic agents. With a total of 2 patents, her work focuses on innovative treatments for various diseases.
Latest Patents
Morimoto's latest patents include a therapeutic agent for diseases based on the inhibitory effect of macrophage migration inhibitory factor. This method is designed for treating relapsing-remitting or secondary progressive multiple sclerosis during relapse. It involves administering a benzopyran derivative, which is characterized by specific chemical properties. Another notable patent involves a drug containing a benzophenone derivative or its salt. This pharmaceutical agent is recognized for its suppressive effects on RANKL production and its role in treating conditions such as osteoporosis.
Career Highlights
Kimiko Morimoto is associated with Toyama Chemical Co., Ltd., where she has been instrumental in advancing research and development in her field. Her innovative approaches have garnered attention and respect within the pharmaceutical community.
Collaborations
Morimoto has collaborated with esteemed colleagues, including Yukihiko Aikawa and Keiichi Tanaka, contributing to a dynamic research environment that fosters innovation.
Conclusion
Kimiko Morimoto's work exemplifies the impact of dedicated research in the pharmaceutical industry. Her patents reflect a commitment to developing effective treatments for complex diseases, showcasing her role as a leading inventor in her field.